Sleep and the Cardiovascular System: The Foundation

Sleep and the Cardiovascular System: The Foundation

Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Information is based on current medical literature and clinical guidelines but may not apply to your specific situation. Individual responses vary based on personal medical history and concurrent conditions. Always consult qualified healthcare providers for medical decisions. Never delay seeking medical care based on content you’ve read. If experiencing a medical emergency, seek immediate medical attention.

These articles provide education to enhance your healthcare partnership. All treatment decisions should involve your healthcare team. Use this knowledge to have informed discussions, not replace medical care.

In Brief: You spend about a third of your life asleep, and during that time the cardiovascular system works very differently than it does awake. In deep non-REM sleep, blood pressure falls, heart rate slows, and sympathetic (fight-or-flight) activity drops to its lowest of the day — reduced workload for the heart and vessels that happens at no other time. REM sleep does not provide this recovery; its autonomic swings look more like wakefulness. When sleep is consistently short, fragmented, or mistimed, that recovery is lost, and large studies link poor sleep to higher rates of hypertension, coronary disease, and stroke. None of it can be felt — which is why this article covers what happens to the heart across the stages of sleep, how sleep is measured, and why it belongs alongside cholesterol and blood pressure.

Sleep Is a Cardiovascular Exposure

You spend roughly a third of your life asleep — about 2,900 hours a year, more than you spend exercising or eating. We are used to thinking about cardiovascular risk as exposure: years of high LDL, high blood pressure, or smoking. Sleep is an exposure too, and a large one — on the order of 175,000 hours across an adult lifetime — but it is the one almost no one counts. During every one of those hours, the heart and blood vessels are either recovering or they are not, and you cannot feel which.

This article is the foundation for a 14-part series on sleep and cardiovascular health. It explains what sleep physiologically is, how each stage affects the heart and blood vessels, how sleep quality is measured, and why sleep disorders damage the cardiovascular system silently rather than only making you tired. The relationship also runs both ways: cardiovascular disease can itself disrupt sleep.

If you have coronary artery disease, hypertension, heart failure, or atrial fibrillation — or you are working to prevent them — sleep belongs in the same category as cholesterol and blood pressure: a modifiable factor with direct cardiovascular consequences. Article 2 examines how much sleep is enough and what “quality” means; Articles 3 through 14 cover the specific disorders and the conditions they intersect with.

The Architecture of Sleep

Sleep Is Not One State

Thinking of sleep as a single on/off condition misses everything that matters. Sleep is a structured progression through distinct physiological states, each with different brain activity, muscle tone, hormone release — and different effects on the heart and blood vessels.

There are two fundamental categories:

• NREM sleep (non-rapid eye movement): The majority of sleep in healthy adults, divided into three progressively deeper stages. Brain activity slows, and this is when cardiovascular recovery occurs.(1)
• REM sleep (rapid eye movement): Roughly a fifth to a quarter of sleep. Brain activity resembles wakefulness, vivid dreaming occurs, and — cardiovascularly — this stage is unstable, behaving more like being awake than being in NREM sleep.(1)

These proportions shift with age, medications, alcohol, and sleep disorders, which is one reason those factors influence cardiovascular health.(1)

The Stages at a Glance

The table below summarizes the stages and their cardiovascular effect. The pattern is the key takeaway: the deeper the sleep, the more the heart and blood vessels recover.(1)

Anything that prevents deep sleep — sleep apnea, fragmentation, shortened sleep — reduces the time the cardiovascular system spends recovering.(1)

How Sleep Depth Is Measured: Brain Waves

Sleep stages are defined by electrical patterns in the brain, recorded by EEG (electroencephalogram). As sleep deepens, brain waves slow down and grow larger.(1)

The slowest, largest waves — delta waves — occur during the deepest sleep, which is also when cardiovascular recovery is greatest. During REM, paradoxically, brain waves speed up and resemble wakefulness even though the body is paralyzed, which is part of why REM does not deliver the same cardiovascular recovery as deep NREM.(1)

The Stages in Detail

Stage N1 — the threshold. N1 is the doorway between wakefulness and sleep, lasting only minutes at a time and making up about 5% of the night. Brain waves shift from alpha to slower theta, muscle tone decreases, and you can be woken easily and may not realize you were asleep. Cardiovascularly there is minimal change from quiet wakefulness. N1 is how you get to restoration, not where it happens.(1)

Stage N2 — true sleep. N2 is the first stage of unambiguous sleep and the largest single stage, about half the night. It features sleep spindles (brief bursts of activity that help block external stimuli) and K-complexes (large waveforms that suppress arousal). Body temperature drops, heart rate begins slowing, and blood pressure begins falling. N2 is the staging area, where cardiovascular parameters shift toward their nocturnal pattern.(1)

Stage N3 — deep sleep, where recovery happens. N3 is the deepest, hardest-to-wake, and most restorative stage, and the most important for cardiovascular health. Brain activity is dominated by slow, high-amplitude delta waves. This is when growth hormone secretion peaks, immune function and tissue repair are enhanced, and the brain’s glymphatic waste-clearance system is most active.(1, 2) For the heart and blood vessels, it is the lowest-demand stretch of the day — the physiology of which is covered in the cardiovascular section below.

N3 is concentrated in the first third of the night — the first sleep cycle contains the longest N3 period, and by the fourth or fifth cycle N3 may be minimal or absent.(1) This timing has direct consequences. Going to bed late can truncate total N3 time; waking early costs mostly REM and leaves N3 largely intact; and sleep that is fragmented throughout the night may never reach sustained N3 at all, losing the recovery even when time in bed looks adequate.

Stage REM — the paradox. Brain waves speed up and resemble wakefulness, vivid dreaming occurs, and voluntary muscles are paralyzed.(1) REM is concentrated in the second half of the night, which is why dream recall is most common on waking. Despite the active, wake-like brain, REM does not provide the cardiovascular recovery that deep NREM does — the reason it is the paradox of the night.

How the Night Is Structured: Sleep Cycles

Sleep does not move linearly from light to deep to REM — it cycles. A complete cycle (N1 → N2 → N3 → back to N2 → REM) takes about 90 minutes, and a typical night contains four to six cycles.(1)

The structure matters as much as the total. Deep sleep — when recovery occurs — is front-loaded into the early night; REM, with its cardiovascular instability, is back-loaded. Two people who both sleep six hours can have very different physiology depending on when those hours fall and whether they are continuous.

What Controls Sleep

Sleep timing and depth are governed by two interacting systems.(6)

Process S — sleep pressure. The longer you are awake, the stronger the drive to sleep. The mechanism is adenosine, a byproduct of brain metabolism that accumulates during wakefulness and binds to receptors that inhibit wake-promoting neurons. During sleep, adenosine clears. Caffeine blocks adenosine receptors — it does not reduce the adenosine, it prevents you from feeling the sleep pressure that is still building.(6, 30)

Process C — circadian rhythm. Independent of how long you have been awake, a roughly 24-hour internal clock promotes wakefulness by day and sleep at night. The master clock is the suprachiasmatic nucleus, a cluster of about 20,000 neurons in the hypothalamus that receives direct input from the eyes; light synchronizes it to the day-night cycle.(6, 29) This system sets the daily rhythms of body temperature (lowest around 4–5 AM), cortisol (peaks early morning), melatonin (rises in evening darkness), and alertness (dips mid-afternoon).(6)

The circadian system does more than control sleepiness — it directly shapes cardiovascular parameters. Blood pressure, heart rate, and vascular tone all follow circadian patterns, and the morning surge in cortisol and sympathetic activity is associated with the well-documented clustering of heart attacks and strokes in the early morning hours.(13) When the circadian rhythm is disrupted by shift work, jet lag, or irregular schedules, both sleep quality and cardiovascular regulation suffer.(26)

The two processes explain why you cannot simply “bank” sleep or shift your schedule at will. In the morning, low sleep pressure plus circadian alerting makes you alert. In the afternoon, a circadian dip produces the familiar post-lunch lull. By evening, accumulated sleep pressure plus a circadian shift toward sleep readies you for bed.

How Much Sleep You Need — and Whether You’re Getting It

Sleep Need by Age

Sleep need varies by age and, to a degree, by individual.(7)

Genuine individual variation exists — some adults need nine hours and others function well on seven, largely for genetic reasons.(8) But most people who believe they “only need 5–6 hours” are chronically sleep-deprived and have adapted to the impairment. True short sleepers, who need under six hours with no impairment, are uncommon and often carry specific genetic variants.(8) Signs you are not meeting your need include requiring an alarm to wake, daytime drowsiness in quiet settings, sleeping much longer on weekends, falling asleep within minutes of lying down (a sign of high sleep pressure), and relying on caffeine to function.

Sleep also changes with age in predictable ways: total sleep time decreases modestly, N3 decreases substantially, sleep becomes more fragmented, the circadian rhythm shifts earlier, and sleep efficiency falls.(1, 6) These are normal, but they mean older adults have less N3 reserve to lose and may be more vulnerable to the cardiovascular consequences of sleep disruption.(1)

What “Sleep Quality” Actually Means

In everyday conversation “quality” is vague; in sleep medicine it has specific, measurable components.(1)

• Sleep latency — time from lights out to falling asleep. Typically under 20–30 minutes; very short (under 5 minutes) suggests excessive sleep debt.(1, 3)
• Wake after sleep onset (WASO) — time awake after first falling asleep. Typically under 30 minutes in younger adults, often higher with age; elevated WASO indicates fragmentation.(1)
• Sleep efficiency — time asleep divided by time in bed. A common benchmark is above 85%.(1)
• Arousal index — arousals per hour. Typically under 10–15; in severe sleep apnea it can be markedly elevated.(1, 15)
• Sleep architecture — the proportion and distribution of stages, which can be abnormal even when total sleep time is normal.(1)

This is why time in bed tells you almost nothing on its own. Consider two people who each spend eight hours in bed. One falls asleep in 15 minutes, is awake 30 minutes overnight, runs 90% efficiency with a normal stage distribution, and gets genuine restorative sleep. The other takes 45 minutes to fall asleep, is awake 90 minutes overnight, runs 75% efficiency with a fragmented architecture, and gets little cardiovascular recovery. Same hours in bed, very different physiology.(1)

Why You Can’t Judge Sleep by How You Feel

The difficult part is that you cannot feel whether sleep is protecting you. Whether your blood pressure dips at night, how much time you spend in deep sleep, how many times you wake without remembering — none of these produce a sensation. People with severe sleep apnea, non-dipping blood pressure, or heavily fragmented sleep frequently report feeling fine, in the same way that people with high LDL or early coronary plaque feel fine. The body gives no warning for any of them. In practice, the person most certain they sleep well is sometimes the one whose partner describes long pauses in breathing and gasping through the night — two accounts of the same sleep that could not be more different.

Chronic short sleep makes self-assessment worse, not better. People adapt to the deficit and stop perceiving it as abnormal, even as measurable impairment persists.(3) The practical consequence is that “I sleep fine” is not evidence that sleep is doing its cardiovascular job — only that nothing has forced the problem into the open yet. It is the same silent pattern as high blood pressure, high cholesterol, and early atherosclerosis, and the reason sleep has to be measured rather than judged by feel.

How Sleep Affects the Cardiovascular System

The Autonomic Nervous System Is the Link

The connection between sleep and the heart runs through the autonomic nervous system, the body’s automatic control system, which has two branches. The sympathetic branch (“fight or flight”) increases heart rate, constricts blood vessels, raises blood pressure, and dominates during wakefulness, activity, and stress.(11) The parasympathetic branch (“rest and digest”), primarily the vagus nerve, slows heart rate, promotes vasodilation, lowers blood pressure, and increases during relaxation and sleep.(12) The balance between them shifts across sleep stages — and that shift is the measurable, physiological event that either protects the cardiovascular system or fails to.(11, 12)

Deep NREM sleep and REM sit at opposite ends of that balance:

The table compares typical patterns in healthy sleep; in disorders such as sleep apnea, these distinctions break down, which is the subject of later articles.

NREM Sleep: Recovery in Numbers

During NREM sleep, particularly N3, the cardiovascular system enters its most protected state.(9, 11, 12, 14) Heart rate falls to its lowest point of the 24-hour cycle.(9) Blood pressure drops 10–20% below daytime values and stays down across NREM periods, giving vessel walls hours of reduced mechanical stress.(14) Sympathetic nerve activity decreases substantially — this has been directly measured with microneurography, which records actual nerve firing.(11) Parasympathetic (vagal) tone rises, and heart rate variability increases in its parasympathetic component.(12) Cardiac output falls with the lower heart rate and reduced metabolic demand.(9)

The practical meaning differs by condition. For someone with coronary artery disease, N3 is hours of reduced demand on heart muscle that may have a compromised blood supply. For someone with hypertension, it is hours of blood pressure reduction that no single medication replicates. For everyone, it is the period when the autonomic balance shifts decisively toward recovery.

REM Sleep: Instability

REM looks more like wakefulness than like NREM. Sympathetic activity becomes highly variable with bursts that can reach or exceed waking levels, heart rate fluctuates, blood pressure surges and the sustained nocturnal dip largely disappears, and breathing becomes irregular, which can worsen oxygen desaturation in people with underlying lung or airway problems.(1, 11, 12) Cardiac arrhythmias and acute myocardial infarction show circadian peaks in the early morning hours, when REM is most prevalent and sympathetic activity surges on waking; the specific contribution of REM physiology to arrhythmia risk remains under active investigation.(13)

None of this makes REM harmful or expendable. It is essential for memory consolidation and emotional processing, and a healthy night requires it.(4, 5) It simply is not a period of cardiovascular rest.

Nocturnal Dipping: A Marker Worth Knowing

Nocturnal dipping — blood pressure falling during sleep relative to daytime — is one of the few ways to objectively assess whether sleep is delivering cardiovascular recovery.(14)

• Normal dipping: systolic pressure falls ≥10% from daytime to nighttime average.(14)
• Non-dipping: systolic pressure falls <10%, associated with more heart attacks, strokes, and target-organ damage, independent of 24-hour average pressure.(14)
• Reverse dipping (riser pattern): pressure rises at night, associated with even higher risk.(14)

Common causes of non-dipping include obstructive sleep apnea, diabetes with autonomic dysfunction, chronic kidney disease, heart failure, sleep fragmentation from any cause, some medications, and high sodium intake in salt-sensitive individuals.(1, 14, 15, 16) The clinical point is concrete: dipping status can only be seen on ambulatory blood pressure monitoring — a cuff worn for 24 hours. Office measurements cannot detect it.(14)

The Scale of the Exposure

Sleep is not a minor cardiovascular variable. At roughly eight hours a night, it is about 2,900 hours a year and around 175,000 hours over a 60-year adult life. If healthy NREM sleep provides five to six hours of reduced cardiovascular demand each night, that is roughly 2,000 hours a year of lower blood pressure, slower heart rate, reduced sympathetic activation, and decreased cardiac workload. When sleep apnea fragments sleep, chronic insomnia shortens it, or shift work mistimes it, those protective hours are lost night after night. Over years, that lost recovery time adds up to a measurable cardiovascular burden.

What Happens When Sleep Is Disrupted

Shortened Sleep

Cutting sleep short reduces time in the NREM recovery state, and the consequences appear in both experimental and population studies.(17, 18, 19, 20, 21, 22) In sleep-restriction experiments — healthy volunteers limited to four to six hours for days to weeks — blood pressure rises, sympathetic activity increases, heart rate variability falls, endothelial function is impaired, inflammatory markers (CRP, IL-6) rise, insulin resistance develops, and cortisol patterns shift.(17, 18, 19, 20, 21) These effects appear within days and reverse with recovery sleep, which points to functional dysregulation rather than immediate structural damage — but chronic short sleep means chronic exposure.(3)

In population studies, a meta-analysis pooling over 470,000 participants found short sleep (typically under six hours) associated with roughly a 48% higher risk of developing or dying from coronary heart disease.(22) A relative figure like that only means something next to a baseline: applied to a person at low short-term risk it is a modest absolute increase, while across a large population it adds up to a meaningful number of events. Short sleep is also associated with incident hypertension, type 2 diabetes, and stroke.(23, 24, 25) Association is not proof of causation, and poor sleepers may differ in other ways. But the consistency across diverse populations, the dose-response relationships, and the alignment with the experimental mechanisms together make it reasonable to treat short sleep as a cardiovascular risk factor.(17, 18, 19, 20, 21, 22)

Fragmented Sleep

Fragmentation — frequent arousals that interrupt continuity — may be as harmful as shortened sleep, even when time in bed looks adequate.(15) Each arousal, even a brief 3–15 second awakening, triggers a surge of sympathetic activity, a transient spike in blood pressure and heart rate, and a shift away from NREM physiology.(11) When arousals occur 30–60 times an hour, as in moderate-to-severe obstructive sleep apnea, the cardiovascular system is pulled out of recovery every minute or two all night long.(15) A person with severe sleep apnea can spend eight hours in bed and obtain essentially no sustained N3. This is why fragmentation can be worse than short consolidated sleep: five uninterrupted hours at least deliver concentrated early-cycle N3, whereas eight fragmented hours may never reach it.(1, 15)

Circadian Disruption

Sleeping at the wrong circadian time, as in shift work and jet lag, impairs sleep quality even when duration is adequate.(6) Sleep initiated during the circadian day is lighter and more fragmented, deep N3 is harder to achieve against the drive for wakefulness, and the nocturnal blood pressure dip may not occur.(6) Shift workers show higher rates of coronary events and stroke,(26) reflecting chronic circadian misalignment, poor daytime sleep, disrupted meal timing, and associated lifestyle factors. Irregular timing matters even without formal shift work: large swings between weekday and weekend sleep schedules pull the circadian clock back and forth, and this everyday pattern is examined in Article 2 and the article on circadian disruption.

Sleep and the Wider Cardiometabolic System

These effects do not stay confined to blood pressure and heart rate. Sleep loss raises sympathetic activity, shifts cortisol patterns, and reduces insulin sensitivity — changes that push toward the insulin resistance underlying metabolic syndrome and type 2 diabetes.(19) In HeartBuddi’s framework, sleep is not an isolated input but one node in the network linking sympathetic tone, metabolic regulation, blood pressure, and vascular injury. The metabolic side of that connection is examined in the article on sleep and cardiometabolic disease.

Sleep and Vascular Biology

The acute effects of poor sleep — elevated pressure, sympathetic activation, reduced heart rate variability — are reversible. The question is whether chronic exposure accumulates into structural vascular damage.(17, 18, 19, 20, 21)

Endothelial dysfunction. The endothelium is the single-cell layer lining every blood vessel; it produces nitric oxide to dilate vessels, prevents inappropriate clotting, and controls inflammation. Sleep restriction reduces flow-mediated dilation, a measure of the endothelium’s ability to produce nitric oxide.(20) The impairment appears within days and reverses with recovery sleep, but chronic endothelial dysfunction is an early step in atherosclerosis, so the short-term effect may carry long-term consequences.(20)

Inflammation. Sleep deprivation activates inflammatory pathways, raising CRP, IL-6, and TNF-α — mediators central to atherosclerosis from initial injury through plaque development to rupture.(21) Whether this inflammatory activation meaningfully drives long-term atherosclerosis in humans is biologically plausible but not definitively proven.(21)

Subclinical atherosclerosis on imaging. An analysis from the CARDIA study found shorter sleep duration associated with greater coronary artery calcification, a marker of plaque burden.(27) The PESA study found both short and fragmented sleep associated with more atherosclerosis on carotid and femoral ultrasound and coronary CT.(28) These are observational associations, not proof of causation — poor sleepers may differ in stress, circumstances, or underlying conditions that affect both sleep and vascular health.(27, 28) But the consistency across studies, the dose-response relationships, and the alignment with experimental mechanisms support biological plausibility: the association is likely real, even if the precise causal contribution is uncertain.(17, 18, 19, 20, 21, 27, 28)

Assessing Your Own Sleep

Not everyone with poor sleep has obvious symptoms, but certain patterns warrant attention. Symptoms that may indicate a sleep disorder include loud snoring (especially with witnessed pauses or gasping), waking unrefreshed despite adequate time, excessive daytime sleepiness in passive situations, morning headaches, frequent nighttime urination, difficulty staying asleep, and restless legs. Cardiovascular patterns that should prompt a look at sleep include hypertension that is hard to control on multiple medications, non-dipping blood pressure on ambulatory monitoring, atrial fibrillation (particularly if predominantly nocturnal), heart failure with nocturnal symptoms, and stroke or TIA when other risk factors are well controlled.

Sleep disorders are underdiagnosed for understandable reasons. The events occur while a person is unconscious, so the most telling signs — snoring, gasping, breathing pauses, restlessness — are usually noticed by a bed partner rather than the patient. Symptoms such as fatigue develop slowly and are easy to normalize or attribute to age, work, or stress. And historically, cardiovascular care concentrated on the risk factors that were easiest to measure and treat, while the tools that clarified sleep’s role — polysomnography, ambulatory blood pressure monitoring, and direct autonomic measurement — became widely available only more recently. The result is that many people with cardiovascular disease have a sleep disorder that has never been identified. When a sleep study does finally happen, the trigger is often not the patient’s own complaint but someone or something else: a partner who can no longer sleep through the gasping, blood pressure that will not come down on three medications, an episode of dozing at the wheel, or atrial fibrillation that keeps returning after treatment.

What Gets Measured

• Ambulatory blood pressure monitoring (ABPM): a cuff worn for 24 hours, the only way to assess dipping status, nocturnal hypertension, and morning surge. Office readings cannot detect these.(14)
• Polysomnography (PSG): the comprehensive in-lab study, monitoring brain waves, eye movements, muscle activity, breathing, oxygen, and heart rhythm. It defines sleep apnea severity by the apnea-hypopnea index (AHI: <5 normal, 5–15 mild, 15–30 moderate, >30 severe) and reports oxygen nadir, time below 90% saturation, arousal index, efficiency, and architecture.(10)
• Home sleep apnea testing (HSAT): a simplified at-home study measuring breathing, oxygen, and sometimes heart rate. It cannot stage sleep, may underestimate severity because it often uses recording time rather than actual sleep time as the denominator, and is best suited to diagnosing moderate-to-severe OSA in patients with high pretest probability; it may miss milder cases or central sleep apnea.(10)
• Consumer wearables: useful for tracking trends and estimating total sleep time, but they cannot accurately stage sleep, diagnose sleep apnea, measure oxygen reliably, or tell you whether cardiovascular recovery occurred. A wearable suggesting poor sleep is worth investigating, but it cannot tell you why.(31)

Clinicians generally consider a sleep evaluation when there are symptoms of sleep apnea, cardiovascular disease in which sleep may contribute, hypertension that is difficult to control, atrial fibrillation (especially nocturnal or recurrent after treatment), heart failure with nocturnal symptoms, non-dipping or reverse dipping on monitoring, or persistent unrefreshing sleep despite adequate time. The threshold for evaluation is lower in patients with established cardiovascular disease, where sleep disorders are common and frequently undertreated.(1)

What This Means for You

If you have no known cardiovascular disease, sleep is primary prevention and belongs alongside not smoking, a healthy diet, regular exercise, and a healthy weight. Protect duration (7–9 hours for most adults), protect continuity (fragmented sleep may be worse than short consolidated sleep), keep timing regular, and take warning signs — loud snoring, unrefreshing sleep, daytime sleepiness — to your clinician.(6, 7, 10, 15, 22, 23, 24, 25, 26)

If you have hypertension, sleep may be contributing directly and may explain difficult-to-control pressure. Resistant hypertension — blood pressure that stays high despite three or more medications — is one of the most reliable reasons to look for sleep apnea. Ambulatory monitoring can assess dipping status, and treating a sleep disorder may improve blood pressure more than adding another medication.(14, 15) This connection is covered further in the article on insomnia and the article on sleep medications and cardiovascular safety.

If you have coronary artery disease, N3 is when the heart operates at lowest demand. It is worth asking whether your sleep is providing that protection and whether symptoms like fatigue or poor exercise tolerance might be partly sleep-related.(9, 11, 12, 14)

If you have heart failure, sleep disorders are extremely common and contribute to symptoms and progression. The relationship runs both ways: heart failure itself disrupts sleep, and central sleep apnea — a different pattern from obstructive — is common in heart failure, with treatment that differs from treatment in patients without it. This is covered in the articles on central sleep apnea and on sleep optimization.

If you have atrial fibrillation, sleep apnea is more common than in matched controls and has been associated with AF recurrence after cardioversion and ablation. A sleep evaluation is worth discussing, especially if AF is difficult to control or recurs after treatment — covered in the article on sleep and cardiometabolic disease.

Common Assumptions Measured Against the Physiology

The Bottom Line

Sleep is not downtime for the cardiovascular system — it is when much of the heart and vessels’ daily recovery happens, and it happens then or not at all. During deep NREM sleep, blood pressure falls, heart rate slows, and sympathetic activity drops to its lowest of the day, giving the cardiovascular system hours of reduced workload it gets at no other time. No medication reproduces that full pattern: you can lower blood pressure or slow the heart with drugs, but you cannot replace what deep sleep does. When sleep is short, fragmented, or mistimed, that recovery is lost, and over years the cost is real — blood pressure that no longer dips at night, vessels under longer daily stress, and higher rates of hypertension, coronary disease, and stroke. Modern medicine routinely measures blood pressure, cholesterol, and glucose, yet far fewer people know whether their pressure dips at night or how much deep sleep they get — even though sleep occupies nearly a third of life and acts on many of the same pathways our cardiovascular drugs target. For anyone living with cardiovascular disease or working to prevent it, sleep is a major part of the picture that usually goes unmeasured — and unlike how rested you feel, it can actually be measured and changed.

What Comes Next

Article 2 turns to how much sleep is enough — the U-shaped risk curve, and why quality, not just hours, determines whether sleep protects the heart. Article 3 begins the disorders with obstructive sleep apnea, the most common and most underdiagnosed of them.

Key Terms

NREM sleep (non-rapid eye movement sleep): Sleep stages N1, N2, and N3, with progressively slower brain waves. N3 (deep or slow-wave sleep) is when cardiovascular recovery occurs and is concentrated in the first third of the night.(1)

REM sleep (rapid eye movement sleep): The stage with rapid eye movements, vivid dreaming, muscle paralysis, and wake-like brain activity. Cardiovascularly unstable and concentrated in the second half of the night.(1)

Sleep architecture: The structure and pattern of sleep stages across the night.(1)

Sleep cycle: A complete progression through NREM stages and REM, typically about 90 minutes; a normal night contains four to six.(1)

Process S (sleep pressure): The homeostatic drive to sleep, mediated by adenosine accumulation during wakefulness.(6)

Process C (circadian rhythm): The internal ~24-hour clock, governed by the suprachiasmatic nucleus and synchronized by light.(6, 29)

Nocturnal dipping: Blood pressure falling ≥10% during sleep compared to daytime. A marker of intact cardiovascular recovery; non-dipping predicts increased risk.(14)

Sleep efficiency: Time asleep divided by time in bed; a common benchmark is above 85%.(1)

Arousal index: Arousals per hour of sleep; a common benchmark is under 10–15. Elevated values indicate fragmentation.(1)

AHI (apnea-hypopnea index): Breathing disturbances per hour of sleep, defining sleep apnea severity: <5 normal, 5–15 mild, 15–30 moderate, >30 severe.(10)

Sympathetic nervous system: The autonomic branch that raises heart rate, constricts vessels, and raises blood pressure; activity decreases during NREM sleep.(11)

Parasympathetic nervous system: The autonomic branch (primarily the vagus nerve) that slows heart rate and supports restoration; activity increases during NREM sleep.(12)

Endothelium: The single-cell layer lining blood vessels; regulates vascular tone, clotting, and inflammation, and is impaired by sleep deprivation.(20, 21)

Heart rate variability (HRV): Beat-to-beat variation in heart rate; higher HRV generally reflects parasympathetic activity and increases during NREM sleep.(12)

References

1. Carskadon MA, Dement WC. Normal human sleep: an overview. In: Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine. 6th ed. Elsevier; 2017:15-24.
2. Xie L, Kang H, Xu Q, et al. Sleep drives metabolite clearance from the adult brain. Science. 2013;342(6156):373-377. doi:10.1126/science.1241224.
3. Banks S, Dinges DF. Behavioral and physiological consequences of sleep restriction. J Clin Sleep Med. 2007;3(5):519-528. doi:10.5664/jcsm.26918. PMID: 17803017.
4. Walker MP, Stickgold R. Sleep-dependent learning and memory consolidation. Neuron. 2004;44(1):121-133. doi:10.1016/j.neuron.2004.08.031. PMID: 15450165.
5. Walker MP. The role of sleep in cognition and emotion. Ann N Y Acad Sci. 2009;1156:168-197. doi:10.1111/j.1749-6632.2009.04416.x. PMID: 19338508.
6. Borbély AA, Daan S, Wirz-Justice A, Deboer T. The two-process model of sleep regulation: a reappraisal. J Sleep Res. 2016;25(2):131-143. doi:10.1111/jsr.12371. PMID: 26762182.
7. Watson NF, Badr MS, Belenky G, et al. Recommended amount of sleep for a healthy adult: a joint consensus statement of the American Academy of Sleep Medicine and Sleep Research Society. Sleep. 2015;38(6):843-844. doi:10.5665/sleep.4716.
8. He Y, Jones CR, Fujiki N, et al. The transcriptional repressor DEC2 regulates sleep length in mammals. Science. 2009;325(5942):866-870. doi:10.1126/science.1174443.
9. Burgess HJ, Trinder J, Kim Y, Luke D. Sleep and circadian influences on cardiac autonomic nervous system activity. Am J Physiol Heart Circ Physiol. 1997;273(4):H1761-H1768. doi:10.1152/ajpheart.1997.273.4.H1761. PMID: 9362241.
10. Kapur VK, Auckley DH, Chowdhuri S, et al. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(3):479-504. doi:10.5664/jcsm.6506. PMID: 28162150.
11. Somers VK, Dyken ME, Mark AL, Abboud FM. Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med. 1993;328(5):303-307. doi:10.1056/NEJM199302043280502.
12. Tobaldini E, Nobili L, Strada S, Casali KR, Braghiroli A, Montano N. Heart rate variability in normal and pathological sleep. Front Physiol. 2013;4:294. doi:10.3389/fphys.2013.00294. PMID: 24137133.
13. Muller JE, Stone PH, Turi ZG, et al. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med. 1985;313(21):1315-1322. doi:10.1056/NEJM198511213132103.
14. Salles GF, Reboldi G, Fagard RH, et al. Prognostic effect of the nocturnal blood pressure fall in hypertensive patients: the ambulatory blood pressure collaboration in patients with hypertension (ABC-H) meta-analysis. Hypertension. 2016;67(4):693-700. doi:10.1161/HYPERTENSIONAHA.115.06981. PMID: 26902495.
15. Wolf J, Hering D, Narkiewicz K. Non-dipping pattern of hypertension and obstructive sleep apnea syndrome. Hypertens Res. 2010;33(9):867-871. doi:10.1038/hr.2010.153. PMID: 20818398.
16. Spallone V, Bernardi L, Ricordi L, et al. Relationship between the circadian rhythms of blood pressure and sympathovagal balance in diabetic autonomic neuropathy. Diabetes. 1993;42(12):1745-1752. doi:10.2337/diab.42.12.1745. PMID: 8243821.
17. Lusardi P, Zoppi A, Preti P, Pesce RM, Piazza E, Fogari R. Effects of insufficient sleep on blood pressure in hypertensive patients: a 24-h study. Am J Hypertens. 1999;12(1 Pt 1):63-68. doi:10.1016/S0895-7061(98)00200-3. PMID: 10075386.
18. Zhong X, Hilton HJ, Gates GJ, et al. Increased sympathetic and decreased parasympathetic cardiovascular modulation in normal humans with acute sleep deprivation. J Appl Physiol. 2005;98(6):2024-2032. doi:10.1152/japplphysiol.00620.2004. PMID: 15718408.
19. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354(9188):1435-1439. doi:10.1016/S0140-6736(99)01376-8.
20. Sauvet F, Leftheriotis G, Gomez-Merino D, et al. Effect of acute sleep deprivation on vascular function in healthy subjects. J Appl Physiol. 2010;108(1):68-75. doi:10.1152/japplphysiol.00851.2009. PMID: 19910332.
21. Irwin MR, Olmstead R, Carroll JE. Sleep disturbance, sleep duration, and inflammation: a systematic review and meta-analysis of cohort studies and experimental sleep deprivation. Biol Psychiatry. 2016;80(1):40-52. doi:10.1016/j.biopsych.2015.05.014. PMID: 26140821.
22. Cappuccio FP, Cooper D, D’Elia L, Strazzullo P, Miller MA. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J. 2011;32(12):1484-1492. doi:10.1093/eurheartj/ehr007.
23. Gangwisch JE, Heymsfield SB, Boden-Albala B, et al. Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension. 2006;47(5):833-839. doi:10.1161/01.HYP.0000217362.34748.e0. PMID: 16585410.
24. Cappuccio FP, D’Elia L, Strazzullo P, Miller MA. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2010;33(2):414-420. doi:10.2337/dc09-1124. PMID: 19910503.
25. Leng Y, Cappuccio FP, Wainwright NW, et al. Sleep duration and risk of fatal and nonfatal stroke: a prospective study and meta-analysis. Neurology. 2015;84(11):1072-1079. doi:10.1212/WNL.0000000000001371.
26. Vyas MV, Garg AX, Iansavichus AV, et al. Shift work and vascular events: systematic review and meta-analysis. BMJ. 2012;345:e4800. doi:10.1136/bmj.e4800. PMID: 22835925.
27. King CR, Knutson KL, Rathouz PJ, Sidney S, Liu K, Lauderdale DS. Short sleep duration and incident coronary artery calcification. JAMA. 2008;300(24):2859-2866. doi:10.1001/jama.2008.867. PMID: 19109114.
28. Domínguez F, Fuster V, Fernández-Alvira JM, et al. Association of sleep duration and quality with subclinical atherosclerosis. J Am Coll Cardiol. 2019;73(2):134-144. doi:10.1016/j.jacc.2018.10.060.
29. Hastings MH, Maywood ES, Brancaccio M. Generation of circadian rhythms in the suprachiasmatic nucleus. Nat Rev Neurosci. 2018;19(8):453-469. doi:10.1038/s41583-018-0026-z. PMID: 29934559.
30. Fredholm BB, Bättig K, Holmén J, Nehlig A, Zvartau EE. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev. 1999;51(1):83-133. PMID: 10049999.
31. Khosla S, Deak MC, Gault D, et al. Consumer sleep technology: an American Academy of Sleep Medicine position statement. J Clin Sleep Med. 2018;14(5):877-880. doi:10.5664/jcsm.7128. PMID: 29734997.

HeartBuddi • Your heart. Own it.